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Abstract: Oocyte activation is an important process triggered by fertilization
that initiates embryonic development. However, parthenogenetic activation
can occur either spontaneously or with chemical treatments. The LT/Sv
mouse strain is genetically predisposed to spontaneous activation. LT oocytes
have a cell cycle defect and are ovulated at the metaphase I stage instead of
metaphase II. A thorough understanding of the female meiosis defects in this
strain remains elusive. We have reported that AMP-activated protein kinase
(PRKA) has an important role in stimulating meiotic resumption and
promoting completion of meiosis I while suppressing premature
parthenogenetic activation. Here we show that early activation of PRKA during
the oocyte maturation period blocked chemically induced activation in B6SJL
oocytes and spontaneous activation in LT/SvEiJ oocytes. This inhibitory effect
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was associated with high levels of MAPK1/3 activity. Furthermore, stimulation
of PRKA partially rescued the meiotic defects of LT/Sv mouse oocytes in
concert with correction of abnormal spindle pole localization of PRKA and loss
of prolonged spindle assembly checkpoint activity. Altogether, these results
confirm a role for PRKA in helping sustain the MII arrest in mature oocytes
and suggest that dysfunctional PRKA contributes to meiotic defects in
LT/SvEiJ oocytes.
Keywords: AMP-activated protein kinase, chemically induced activation,
LT/SvEiJ strain, mouse, oocyte, spontaneous activation

Introduction
Mammalian oocytes initiate meiosis during embryonic
development and become arrested at the dictyate stage of prophase I
around the time of birth. Following a midcycle gonadotropin stimulus,
oocytes within preovulatory follicles resume meiosis, complete
maturation, and are ovulated at the metaphase II (MII) stage, where
they remain until fertilization. Meiosis is driven by M-phase promoting
factor (MPF), a dimer containing catalytic CDK1 and regulatory cyclin
B1 subunits; MPF activity drops during polar body extrusion, then rises
and stays elevated during MII arrest [1]. Binding of sperm triggers
activation of the mature ovum, a series of events that includes calcium
oscillations, completion of meiosis, release of cortical granules, and
initiation of embryonic development [2, 3]. Calcium signaling is a
universal component of fertilization in the animal kingdom [4]; in
vertebrates, calcium oscillations are an essential feature of egg
activation and trigger release from MII arrest [5, 6]. This arrest is
controlled by cytostatic factor (CSF), which involves stabilization of
maturation promoting factor by the c-Mos/MAPK1/3 pathway and
suppression of the anaphase promoting complex (APC) by early mitotic
inhibitor 2 (Emi2) [7]. Indeed, interrupting the c-Mos/MAPK1/3
pathway leads to loss of MPF activity and premature egg activation [8–
10]; in addition, knockdown of Emi2 allows degradation of cyclin B of
MPF and drives eggs into anaphase II [11, 12], mimicking the effect of
sperm-induced calcium oscillations [13, 14].
Oocyte aging, chemical treatment, and the intrinsic quality of
the oocyte are factors that can lead to mouse egg activation in the
absence of sperm [15]. It is well known that freshly ovulated oocytes
are resistant to activation but become prone to activation with
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increased age and tenure in the oviducts [16–18]. Chemical
treatments such as calcium ionophore [19, 20], phorbol ester [20–22],
protein synthesis inhibitors [23, 24], ethanol [25–27], and heavy
metals [28, 29] are well-characterized inducers of parthenogenesis in
oocytes matured both in vivo and in vitro. There are strain-dependent
differences in oocyte susceptibility to spontaneous maturation [30],
while altering metabolism or length of hormonal priming can induce
parthenogenesis in strains that normally exhibit very low rates of
activation [31, 32].
The LT/Sv strain is an inbred recombinant mouse line derived
from C58 and BALB strains whose oocytes fail to complete meiosis,
leading to arrest at metaphase I [33–36], due to persistent MPF
activity and a poor anaphase I trigger [36–39]. This MI arrest is
associated with premature activation of oocytes within the ovary and a
high incidence of ovarian teratomas [40–42]. The parthenotes advance
to the egg cylinder stage, but further development is disrupted, with
formation of a disorganized mass of differentiated cell types [40]. A
significant number of LT/Sv oocytes are ovulated at the metaphase I
stage, and this arrest appears necessary but not sufficient to induce
parthenogenetic activation [43, 44]. Apparently, the protracted MI
arrest brings about changes within the oocyte that predispose it to
activation. The exact mutation(s) of the LT/Sv mouse remains
unknown, but evidence suggests that the phenotype of LT/Sv oocytes
is controlled by multiple alleles [42, 43].
We have previously demonstrated a role for AMP-dependent
protein kinase (PRKA) in mouse oocyte maturation. This kinase is a
critical regulator of metabolism and cell cycle that responds to changes
in stress and energy deficit [45]. The activation of PRKA in mouse
oocytes not only induces meiotic resumption [46–48] but also
promotes first polar body (PB) formation [32]. Active PRKA localizes to
chromosomes and the meiotic spindle poles during maturation [32],
and this association pattern is dependent on spindle/microtubule
integrity [49]. Moreover, blocking PRKA activity with the specific
inhibitor compound C induces premature egg activation, whereas
treatment with the PRKA activator AICAR suppresses the activation
that occurs during spontaneous maturation of oocytes from unprimed
and 1-day-primed mice [32]. This latter finding implicated PRKA in the
regulation of activation in mouse oocytes.
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Society for the Study of Reproduction.

3

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

In this study, we further examined the relationship between
PRKA and oocyte activation. We report that PRKA activators suppress
both chemically induced activation in oocytes from C57BL/6J×SJL F1
(B6SJL) mice and spontaneous activation in oocytes from LT/SvEiJ
mice during maturation in vitro but are less effective in ovulated B6SJL
oocytes. This protection by PRKA was manifest during the oocyte
maturation period and was associated with high levels of MAPK1/3
activity and the accelerated loss of the spindle assembly checkpoint
protein MAD2. Stimulation of PRKA in LT/SvEiJ oocytes rescued the “LT
phenotype” by reducing the rate of parthenogenetic activation and
promoting anaphase onset and PB formation. These data support a
multifunctional role of PRKA in mouse oocytes and suggest that PRKA
dysfunction may contribute to meiotic defects in LT/SvEiJ oocytes.

Materials and Methods
Chemicals
Unless otherwise noted, chemicals were supplied by SigmaAldrich Co. (St. Louis, MO). AICAR was from Toronto Research
Chemicals, Inc. (North York, Ontario, Canada) and amphiregulin from
R&D Systems (Minneapolis, MN). Highly purified ovine FSH was
obtained from the National Hormone and Peptide Program and Dr. A.F.
Parlow. Cy3-conjugated donkey anti-rabbit IgG was purchased from
Jackson ImmmoResearch (West Grove, PA), Anti-phospho PRKA
(PT172) antibody from Cell Signaling Technology (Beverly, MA), and
rabbit anti-ERK1/2 and pERK1/2 (MAPK1/3) antibodies from Sigma.
Anti-MAD2 antibody was a kind gift from Dr. E.D. Salmon (University
of North Carolina).

Oocyte Isolation and Culture Condition
All procedures were approved by the Marquette University
Institutional Animal Care and Use Committee. Immature, 20- to 23day-old C57BL/6J×SJL/J F1 (B6SJL) and LT/SvEiJ female mice were
used for all experiments. Mice were primed with 5 IU equine chorionic
gonadotropin (eCG), and oocytes were isolated 2 days later. For
superovulation, 5 IU human chorionic gonadotropin (hCG) were
administered IP 44–48 h post-eCG, and oocytes were isolated at
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varying times thereafter. Mice were killed by cervical dislocation, and
either ovaries or oviducts were removed and placed in a Petri dish
containing culture medium. Cumulus cell-enclosed oocytes (CEO) were
isolated by puncturing the follicles with sterile needles. Denuded
oocytes (DO) were obtained by stripping cumulus cells with a mouthoperated small-bore pipette. Oviducts were punctured with sterile
needles to release the expanded cumulus masses, which were then
treated briefly with hyaluronidase to remove cumulus cells.
Both CEO and DO were washed twice and transferred to
polystyrene round-bottom culture tubes (BD Falcon, Durham, NC)
containing 1 ml of the appropriate test medium. The culture medium
used was Eagle minimum essential medium (MEM) supplemented with
penicillin, streptomycin sulfate, 0.23 mM sodium pyruvate, and 3
mg/ml lyophilized crystallized bovine serum albumin (MP Biomedicals,
Solon, OH). Calcium was omitted from the medium when activation
was stimulated with strontium or calcium ionophore A23187.

Chemical Activation
Figure 1 depicts the three activation schemes used in this study.
CEO or DO were cultured 17 h in control MEM prior to treatment with
chemical activators. Cumulus cells were removed from CEO at the end
of this initial culture period so that only DO received the activation
stimulus. The three activation regimens are as follows:

FIG. 1. Schematic diagram of activation protocols. For all treatment regimens, CEO or
DO were first cultured 17 h in control medium to permit completion of maturation.
When appropriate, cumulus cells were then removed from CEO, and DO were exposed
to chemical activating conditions. A) Oocytes were treated with strontium in calciumfree MEM for 2.5 h, washed, and then transferred to control MEM for 3.5 h. B) Oocytes
were exposed to 7% ethanol for 7 min, washed, and then transferred to control MEM
for 6 h. C) Oocytes were treated with A23187 for 5 min, washed, and then transferred
to puromycin (Pur) for 6 h.

1. Strontium. 2.5 h in calcium-free MEM containing 1 mM strontium,
wash, and 3.5 h culture in control MEM.
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2. A23187/puromycin. 5 min in control MEM containing 5 μM calcium
ionophore A23187, wash, and 6 h culture in control MEM containing 10
μg/ml puromycin.
3. Ethanol. 7 min in control MEM containing 7% EtOH, wash, and 6 h
culture in control MEM.

CEO or DO were exposed to PRKA activators (0.2 mM AICAR, 2 mM
AMP, or 2 μM RSVA405) during meiotic maturation (prematuration) or
during/after the activation procedure (postmaturation). CEO were
hormonally stimulated with 0.1 μg/ml FSH or 50 μg/ml amphiregulin
during meiotic maturation. Oocytes were considered to be activated if
they contained a pronucleus or two polar bodies with or without
pronucleus or had undergone cleavage.

Immunofluorescent Staining
Cumulus cell-free oocytes were fixed with 4% formaldehyde in
PBS at 4°C overnight. They were then permeabilized 30 min with 0.1%
Triton-100 in blocking solution, which contained 10% donkey serum
and 0.5 mg/ml saponin in PBS, followed by 1 h in blocking solution.
Oocytes were incubated with primary antibody (1:100) overnight at
4°C (either rabbit anti-pPRKAThr172 or rabbit anti-MAD2 antibody) and
washed four times at room temperature in blocking buffer. This was
followed by 1 h incubation with FITC-conjugated mouse anti-tubulin
antibody (1:100) and Cy3-conjugated donkey anti-rabbit IgG antibody
(1:100) at room temperature. Some oocytes were stained for actin
using Alexa 568 Fluor phalloidin (Life Technologies, Grand Island, NY)
during the secondary antibody culture period. Oocytes were washed
four times, placed on slides, and mounted with medium containing
DAPI (Vector Laboratories, Burlingame, CA).

Confocal Microscopy
Oocytes were observed on a laser scanning confocal microscope
(Carl Zeiss Co., Thornwood, NY) with a 63× objective. During
scanning, all settings were kept constant (i.e., laser power, detector
gain, amplifier offset, amplifier gain, and pinhole size). Digitally
recorded images were exported by LSM Examiner software (Carl
Zeiss).
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Western Blot Analysis
Oocyte samples were washed with PBS/PVP, then twice with
protease inhibitor cocktail (Roche, Indianapolis, IN). Samples were
lysed by Laemmli buffer with 20% beta-mercaptoethanol at 95°C for 5
min. Electrophoresis was carried out using NuPAGE 4–12% Bis-Tris
Gels (InVitrogen, Carlsbad, CA), and proteins were transferred to
nitrocellulose membranes. Membranes were blocked with 5% nonfat
milk, followed by incubation with rabbit anti-pERK1/2 (pMAPK1/3)
antibody (1:1000) at 4°C overnight. Blots were rinsed twice with TBS
(pH 7.4) and once with TBS-Tween-20 (0.05%), followed by
incubation with HRP-conjugated goat anti-rabbit IgG antibody (1:5000
in 5% nonfat milk; Thermo Scientific Pierce, Rockford, IL) at room
temperature for 1 h. After washing, protein signals were detected by
super signal west pico chemiluminescent substrate (Thermo Scientific
Pierce). Blots were stripped with restore Western blot stripping buffer
(Thermo Scientific Pierce) at room temperature for 15 min and
reprobed with rabbit anti-MAPK1/3 antibody (1:1000). The
pMAPK1/3:MAPK1/3 ratios were quantified with ImageJ software based
on protein band density.

Statistical Analysis
All experiments were repeated at least three times and data
presented as mean ± SEM. Percentages of activation, polar body, or
MAD2 staining underwent arcsin transformation, and data were
analyzed statistically by analysis of variance followed by the Duncan
multiple range test. Student t-test was used to compare paired
treatments in some experiments. A P value < 0.05 was considered
significant.

Results
Effects of PRKA Activators on Chemically Induced
Activation in B6SJL Oocytes
We have previously shown that the PRKA activator AICAR
prevents premature activation in spontaneously activating oocytes
from B6SJL mice when present during meiotic maturation [32]. To test
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if PRKA stimulation would also block activation induced by chemical
treatments, we adopted three different protocols depending on the
agent(s) used to stimulate activation: strontium, A23187/puromycin,
or ethanol. For all three treatments, CEO or DO were cultured 17 h in
control MEM to allow for meiotic maturation. Remaining cumulus cells
were then removed from CEO, and these cumulus cell-free oocytes as
well as the mature DO were exposed to chemical activating conditions
(Fig. 1).

Strontium-induced activation.
The first series of experiments utilized the activating agent
strontium, and cultures were carried out in calcium-free medium since
the absence of calcium has previously been demonstrated to augment
activation by this agent [50]. After removing cumulus cells from
matured CEO, oocytes were exposed to 1 mM strontium in calciumfree MEM for 2.5 h, followed by 3.5 h incubation in control, calciumcontaining medium. In control oocytes not exposed to strontium, only
4% were activated compared to 70% activation in strontium-treated
oocytes (Fig. 2A). When 200 μM AICAR were included in both the
activation and the postactivation media, a modest reduction in the
activation percentage was observed (57%); however, when
supplementation of AICAR was restricted to the initial 17 h oocyte
maturation period, prior to strontium treatment, activation was
reduced to 15% (Fig. 2A). In the next experiment, the direct effects of
AICAR were tested on strontium activation of matured DO, utilizing the
same protocol that was used with CEO. In the absence of cumulus
cells, no activation was observed in the control group, but strontium
stimulated 34–35% of the oocytes to activate. AICAR blocked
strontium-induced activation, and the effect of exposure during meiotic
maturation was comparable to that when exposure followed
maturation (Fig. 2A).
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FIG. 2. Effect of PRKA stimulators and hormones on strontium-induced activation.
Treatment with AICAR (A), AMP (B), or RSVA405 (C) during oocyte maturation
(prematuration) prevented strontium-induced activation in both CEO and DO, but
supplementation after the 17-h maturation period (postmaturation) was relatively
ineffective. D) Amphiregulin (AR) or FSH suppressed strontium-induced activation in
CEO when present during the initial maturation period. E) Effect of delaying AICAR
treatment on strontium-induced activation. The inhibitory effect of AICAR on activation
in CEO was decreased when AICAR treatment was initiated 8 h but not 6 h after the
start of culture. All data are presented as mean percent activated ± SEM. Groups with
no common letter are significantly different (CEO, a–d; DO, w–z).

AICAR is an analog of AMP, and when the experiment was repeated
with native AMP, similar results were obtained. Exposure to AMP
during oocyte maturation reduced the activation rate in CEO from 71%
to 23% (compared to 4% in controls), whereas exposure to AMP
postactivation had no effect (Fig. 2B). When the experiment was
repeated in DO, a similar suppression of activation was obtained if AMP
treatment occurred during the maturation period; however,
surprisingly, treatment postmaturation with AMP increased the level of
activation (Fig. 2B).
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A small-molecule PRKA activator has recently been described
that is an analog of resveratrol, RSVA405 [51]. Supplementary
experiments demonstrated that, like AICAR, RSVA405 promoted GVB
and polar body formation, and its action was suppressed by the PRKA
inhibitor compound C (Supplemental Fig. S1, available online at
www.biolreprod.org). We therefore repeated the strontium activation
experiments, using RSVA405 as the PRKA activator. Consistent with
the AICAR and AMP results, RSVA405 suppressed strontium-induced
activation in both CEO and DO at concentrations that stimulate meiotic
resumption and polar body formation but was effective only when
present during the initial maturation period (Fig. 2C).
Both FSH and the EGF-like peptide amphiregulin (AR) are potent
stimulators of meiotic maturation of mouse CEO in vitro, with
downstream activation of oocyte PRKA preceding GVB [48]. We
predicted that, because of their PRKA-stimulating capability, treatment
of CEO with either of these peptides would block strontium-induced
activation. For this experiment, FSH and AR were present only during
the initial maturation period. These results are shown in Figure 2D. As
predicted, FSH and AR reduced the activation rate, from 77% to 38%
and 33%, respectively.
Since the data indicate that early activation of PRKA within the
oocyte is important for its protective effect on activation, an
experiment was conducted in which exposure of CEO to AICAR was
delayed during the maturation period to determine the required
temporal exposure to achieve maximum protection. There was no loss
of protection when exposure to AICAR was delayed by 6 h; however,
delaying AICAR treatment by 8 h reduced its protective effect by 27%
(Fig. 2E). This suggests that maximum protection requires exposure
within 6 h of the initiation of culture, a time point corresponding to the
early stages of spindle formation.
Since the cMos-MAPK1/3 pathway is important for maintaining
MII arrest [8–10], we tested the effect of PRKA activation in CEO on
MAPK1/3 activity following strontium activation. Oocytes were
collected for Western blot at 17 h (after maturation), 19.5 h
(poststrontium treatment), and 23 h (after final recovery). As shown
in Figure 3, control oocytes that were treated with calcium-free
medium alone maintained a high level of MAPK1/3 activity at all three
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time points. In contrast, oocytes that were treated with strontium
exhibited decreased MAPK1/3 activity after the second and third
culture periods. Consistent with their preventive effect on activation,
both AMP- and AICAR-treated oocytes maintained high MAPK1/3
activity at all time points tested.

FIG. 3. Maintenance of MAPK1/3 activity in oocytes treated with AICAR (AIC) or AMP
during maturation. A) Representative Western blot analysis of p-MAPK1/3 in oocytes
treated as described in Figure 1A. Denuded oocyte extracts were subjected to Western
blot analysis at the end of each of the three treatment phases. +/− in the second
culture indicates the presence or absence of strontium. Con, control. B) Quantitative
analysis of pMAPK1/3 signals from Western blot, presented as a ratio of the band
intensity of pMAPK1/3 to that of nonphosphorylated MAPK1/3. Mean ± SEM of three
blots. Treatments with either AICAR or AMP maintained high pMAPK1/3 levels that
were comparable to the control group. Data are presented as mean ratio ± SEM.

A23187/puromycin-induced activation.
CEO were used to test the ability of AICAR to reverse the
activation resulting from sequential treatment of calcium ionophore
A23187 followed by the protein synthesis inhibitor puromycin. Mature
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oocytes were cultured 5 min in 5 μM calcium ionophore A23187
followed by 6 h in 10 μg/ml puromycin (Fig. 1). In the control group
treated with ionophore alone, only 12% of the oocytes underwent
activation (Fig. 4A). When ionophore-treated oocytes were
subsequently exposed to puromycin, the activation rate was increased
to 66%. If oocytes were exposed to AICAR during puromycin
exposure, there was no significant reduction in activation (43%);
however, a significant decrease occurred when AICAR was present
during the initial maturation period (31% activation; Fig. 4A).

FIG. 4. Treatment with AICAR during but not following oocyte maturation blocked
A23187/puromycin-induced (A) and ethanol-induced (B) activation in CEO. Data are
presented as mean percent activated ± SEM. Groups with no common letter are
significantly different.

Ethanol-induced activation.
CEO were used to test the effect of AICAR on ethanol-induced
activation. When oocytes were exposed for 7 min to 7% ethanol
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followed by 6 h culture in control medium (Fig. 1), 78% of the oocytes
underwent activation compared to 1% of controls (Fig. 4B). If CEO
were treated with AICAR during the initial maturation period, ethanolinduced activation was reduced by 54%, while restricting AICAR
treatment to the last 6 h had no effect.

Effect of PRKA Activation on In Vivo-Aged B6SJL
Oocytes
It has been well documented that increased aging of ovulated
oocytes within the oviduct increases their susceptibility to spontaneous
activation [16–18]. This was confirmed when eggs were retrieved from
the oviducts of superovulated B6SJL mice 16, 20, and 24 h post-hCG
and cultured 6 h in control medium. The percentage of activation
increased in direct relationship to the time post-hCG the eggs were
retrieved (2%, 12%, and 32% activation, respectively); there was a
modest trend for suppression of activation at all time points when
AICAR was present during 6 h culture (0%, 8%, and 22% activation,
respectively; Fig. 5).

FIG. 5. Effect of PRKA on activation of in vivo-matured oocytes. Oocytes were
retrieved from oviducts 16, 20, and 24 h post-hCG and cultured 6 h with or without
AICAR. Although there was a trend toward less activation in AICAR-treated oocytes,
differences were not significant. Data are presented as mean percent activated ± SEM.
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Effects of PRKA Activators on Oocyte Activation in the
LT/SvEiJ Strain
Oocytes from the LT/Sv mouse strain exhibit a high rate of
spontaneous activation [43]. It was therefore important to determine
if PRKA activators would also suppress this type of oocyte activation.
We initially compared spontaneous activation rates in oocytes from
B6SJL and LT/SvEiJ (hereafter designated LT) mice following 30 h
culture in the presence or absence of AICAR. In the absence of AICAR,
activation rates were 2% and 21%, respectively, while AICAR reduced
these rates to 0% and 4% (Fig. 6A). When LT CEO were treated with
RSVA405, a similar reduction in activation was observed (Fig. 6B).

FIG. 6. Effects of PRKA stimulation on LT/SvEiJ oocytes. A) AICAR blocked
spontaneous activation in LT oocytes during 30 h cultures. B) RSVA405 had a similar
inhibitory action on LT activation. Asterisks in A and B denote a significant difference
from controls (Con). C) AICAR blocked activation in LT oocytes when present during
but not after oocyte maturation. LT/Sv oocytes were first cultured in control MEM
(Con) or AICAR for 17 h and then transferred to control or AICAR-supplemented
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medium for another 13 h before activation was assessed. A different letter denotes a
significant difference. D) AICAR stimulated PB formation in both B6SJL and LT oocytes
during 17 h cultures. An asterisk denotes a significant difference from controls (Con).
Data in A–D are presented as percent activation or PB ± SEM. E and F) pPRKA (PT172)
localization (E) and stage of meiosis (F) in MI stage oocytes after 8 h of culture. AICAR
increased the percentage of normal PT172 spindle pole localization in LT oocytes and
increased the percentage of anaphase I (Ana) in oocytes from both the B6SJL and LT
strains. Pro, prometaphase.

To determine the temporal window for AICAR exposure that
protects the LT oocyte from activation, oocytes were first cultured in
control medium or medium containing AICAR for 17 h, then
transferred to control MEM or AICAR-supplemented medium for an
additional 13 h before activation was assessed. As shown in Figure 6C,
high levels of activation were observed in the control/control or
control/AICAR oocyte groups, while significantly lower levels of
activation were observed in the AICAR/AICAR and AICAR/control
groups. These results are consistent with earlier experiments in B6SJL
oocytes showing a protective effect of AICAR during the initial period
of oocyte maturation.
In addition to high rates of spontaneous activation, LT oocytes
also fail to progress past metaphase I both in vivo and during
spontaneous maturation in vitro [33, 38, 52]. Thus, we tested whether
PRKA stimulation could overcome this meiotic defect. CEO from B6SJL
and LT mice were cultured in either control or AICAR-containing
medium for 17 h and assessed for polar body formation. In B6SJL
oocytes, 53% formed polar bodies in control medium, while AICAR
increased this number to 78% (Fig. 6D). No polar bodies were
observed in LT oocytes cultured in control medium, but 22% of AICARtreated oocytes extruded a polar body.
When LT oocytes were stained for active PRKA after 17 h culture
in control medium, we observed a high incidence of abnormal
localization. Instead of staining at both spindle poles, which is the
typical staining pattern in B6SJL oocytes, in most LT oocytes the
localization was either shifted away from the poles or absent at one or
both of the poles (data not presented). Since LT oocytes are arrested
at MI for a prolonged period of time, to eliminate the possibility that
this phenotype was due to an aging effect, we stained oocytes for
active PRKA after 8 h in both B6SJL and LT strains, when MI has been
freshly established, and compared MI localization patterns between the
Biology of Reproduction, Vol 88(3), No. 70 (2013). DOI. This article is © Society for the Study of Reproduction and
permission has been granted for this version to appear in e-Publications@Marquette. Society for the Study of
Reproduction does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Society for the Study of Reproduction.

15

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

two strains. Seventy-five percent of B6SJL MI-stage oocytes cultured
in control medium exhibited active PRKA at both spindle poles (Figs.
6E, E,7A).7A). However, only 28% of LT MI-stage oocytes had similar
bipolar staining, (Figs. 6E, E,7B,7B, and 7C). Treatment with AICAR
had no effect in B6SJL oocytes but doubled the percentage of LT
oocytes with normal PRKA staining (57%).

FIG. 7. A–C) Immunofluorescent staining of active PRKA in LT oocytes. A) Normal
spindle pole localization of active PRKA. B) Shifted spindle pole localization. C) Missing
spindle pole localization. Green, α-tubulin; red, pPRKAThr172; blue, DAPI. D–G)
AICAR treatment accelerated loss of MAD2 in kinetochores. D) Kinetics of centromeric
MAD2 loss in B6SJL oocytes in the presence or absence of AICAR. E) AICAR treatment
eliminated prolonged MAD2 kinetochore localization in LT oocytes. The data in D and E
are presented as percent positive MAD2 stain ± SEM; the asterisk denotes a significant
difference from −AICAR controls. F and G) MAD2 stain in LT oocytes that were
cultured 8 h in control (F) or AICAR-supplemented (G) medium. Red, MAD2; blue,
DAPI.

A comparison of meiotic status in these same oocytes showed
that 97% of B6SJL oocytes cultured 8 h in control medium reached
prometaphase or metaphase I, with 3% in anaphase (Fig. 6F).
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Similarly, 100% of LT oocytes were at metaphase I or prometaphase.
The addition of AICAR accelerated meiotic progression such that 71%
of B6SJL oocytes were at anaphase or beyond after 8 h of culture. In
addition, 33% of LT oocytes were at anaphase after exposure to
AICAR, which, along with the polar body data above, demonstrates
AICAR-induced rescue from metaphase arrest in a significant
percentage of the oocytes.

AICAR Promotes the Loss of Chromosomal MAD2
Staining
Hupalowska et al. [53] previously reported that prolonged
spindle assembly checkpoint (SAC) activity contributes to MI arrest in
LT oocytes. To test the hypothesis that stimulation of PRKA promotes
anaphase onset by overcoming SAC activity, oocytes were stained for
MAD2, one of the major components of SAC [54]. We first determined
the kinetics of centromeric MAD2 loss in B6SJL CEO (Fig. 7D).
Although MAD2 staining intensity was reduced in control oocytes by 6
h, 95% of them still remained positive. Between 6 and 8 h, the
number of MAD2-positive oocytes decreased by 50%. AICAR treatment
accelerated the loss of MAD2, with only 61% and 23% positively
staining oocytes at 6 and 8 h, respectively. In LT CEO, 98% stained
positive for MAD2 after 8 h of culture, whereas in the AICAR-treated
group, it was reduced to 41% (Fig. 7, E, F, and G).

Discussion
In this study, we demonstrate the suppressive effects of PRKA
on parthenogenetic activation in mouse oocytes. Stimulation with the
PRKA activators AICAR, AMP, or RSVA405 during oocyte maturation
prevented both chemically induced activation in B6SJL mice and
spontaneous activation in LT mice, while exposure of oocytes to these
agents after maturation had little effect on either type of activation.
Stimulating PRKA in ovulated, in vivo-matured B6SJL eggs was
relatively ineffective in preventing activation, likely due to the fact that
the eggs were already mature at the time of treatment. Additional
effects of PRKA activation on LT oocytes included changes in active
PRKA localization, release from metaphase arrest, and a reduction in
spindle checkpoint activity.
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Treatment of mouse oocytes with strontium produces repetitive
calcium oscillations that mimic the effect of sperm binding, making it
one of the most effective chemical activating agents [20, 50, 55, 56].
Nevertheless, exposure to AICAR, AMP or RSVA405 was sufficient to
block strontium-induced activation in both CEO and DO, indicating a
direct action on the oocyte. Twice as many oocytes were activated in
CEO compared to DO, confirming that the presence of cumulus cells
during the maturation period promotes activation [57, 58]. The
protection by AMP and AICAR was associated with maintenance of
MAPK1/3 phosphorylation, which suggests that PRKA may prevent
activation by blocking dephosphorylation of MAPK1/3 and keeping MPF
activity high [7]. Activating the cMos/MAPK1/3 pathway in vertebrate
oocytes can induce a CSF arrest [59, 60], while treating oocytes with
inhibitors of MAP2K1 (MEK1), the immediate upstream MAPK1/3
kinase, alleviates metaphase arrest and stimulates activation [9, 61].
Because treatment with PRKA activator and strontium were temporally
separated, it is possible that this action of PRKA may reflect an indirect
upstream effect, preventing an activation stimulus that acts on the
MAPK1/3 pathway. Strontium-induced oocyte activation involves the
interaction of phospholipase and InsP3 receptor [62], and it is possible
that PRKA activation also interferes with these processes [63].
Calcium ionophore A23187 and protein synthesis inhibitors
alone each modestly stimulate oocyte activation, but when oocytes are
treated sequentially with these two agents, synergistic activation is
observed [55, 64–66]. Brief exposure to ethanol is also an effective
trigger for parthenogenetic activation [56, 67, 68]. Though both
treatment regimens cause only single calcium transients, they still
bring about significant levels of activation, and this was confirmed in
the present study, with activation frequencies comparable to those
achieved with strontium. More important, PRKA activators suppressed
both A23187/puromycin- and ethanol-induced activation with a
potency resembling that for strontium-treated oocytes. These results
are important because they demonstrate a consistent activationsuppressing response to PRKA stimulation regardless of the type of
chemical activating stimulus.
Chemically induced parthenogenesis was also suppressed by
hormonal stimulation. The action of FSH and AR in CEO may be
mediated by PRKA within the oocyte because we have previously
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shown that these ligands activate the oocyte kinase in stimulated CEO
[48]. However, it should also be noted that, under such stimulation,
the CEO activation rate was only partially reduced to the level of DO.
Thus, it is also possible that the proactivation cumulus cell influence is
neutralized by hormone-triggered uncoupling of the oocyte from gap
junction-mediated cumulus signals [57], thereby rendering it a
physiologically denuded oocyte that is less sensitive to strontium
stimulation.
PRKA activation during oocyte maturation was essential for
optimal protection from chemically induced activation; later treatment
with PRKA activators during either the activation or the recovery
period was largely ineffective. This relationship was very consistent for
CEO. However, for DO, while prematuration exposure to PRKA
activators was always inhibitory, the results of postmaturation
treatment on activation varied between treatment groups: RSVA405
had no effect, AICAR was inhibitory, and, curiously, AMP was
stimulatory. The reason for these differences is not readily apparent
but could relate to the comparative potency of the treatments in the
presence or absence of the cumulus cells, or perhaps in the case of
AMP there are additional direct actions on the oocyte unrelated to
PRKA activity. This need for PRKA activity during oocyte maturation to
safeguard against activation is consistent with our in vivo oocyte
maturation data since AICAR only marginally prevented the
spontaneous activation of oocytes when exposure occurred after they
completed maturation in vivo. Further, the AICAR timing experiment
showed that treatment with kinase activator could be delayed up to 6
h after the initiation of culture and still achieve full protection against
activation, a time point that roughly corresponds to metaphase spindle
formation. After 6 h, physiological changes begin to manifest in the
oocyte that make it more susceptible to activating conditions that
PRKA activators cannot overcome. Interestingly, this temporal
sensitivity is different than that for PRKA promotion of PB formation,
which requires earlier exposure to PRKA activators, around the time of
GVB [32]. Thus, PRKA not only induces initiation of meiotic resumption
and promotes PB but also suppresses oocyte activation, though the
data suggest its action is required at different time points during the
maturation period to achieve these effects.
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Most LT oocytes are unable to complete meiosis in a timely
fashion, arresting at the MI stage [33–36], and this meiotic
attenuation is important in the spontaneous activation phenotype [43].
Exposure to PRKA activators was not only effective against chemically
induced activation in B6SJL oocytes but also blocked the spontaneous
activation of LT oocytes; again, the PRKA activity was needed during
the initial maturation period for optimal protection. Based on results of
the Western blot analysis of MAPK1/3 phosphorylation in B6SJL
oocytes, it is reasonable to propose that PRKA also suppressed
MAPK1/3 dephosphorylation in LT oocytes and sustained elevated MPF
activity that protected against activation. Consistent with this idea,
MAPK1/3 activity remains high in LT oocytes throughout the period of
MI arrest [35]. Activation of PRKA could prevent the loss of this
activity and the escape from MI arrest that accompanies activation.
Hirao and Eppig [38, 39] suggested a role for CSF in the prolonged MI
arrest in LT oocytes; however, in wild-type oocytes, high CSF activity
did not initiate the MI arrest but only delayed the metaphase-toanaphase transition, which suggested that CSF is not the primary
cause of metaphase I arrest in this strain, though it may help maintain
it.
If the MI arrest in LT oocytes is, indeed, linked to
parthenogenesis, then it is not surprising that PRKA also stimulated
meiotic progression past this arrest point. To further address possible
downstream mediators of PRKA, we investigated whether PRKA altered
spindle assembly checkpoint (SAC) dynamics. SAC is a surveillance
mechanism that monitors the integrity of the meiotic spindle and
proper attachment of chromosomes to spindle microtubules and
controls activation of the APC [69–71]. MAD2 is a SAC protein in
mouse and rat oocytes that localizes to unattached kinetochores,
sequestering the main component of APC, Cdc20, thereby inhibiting
APC activity and keeping MPF activity high [72, 73]. MAD2 is required
in mouse oocytes for maintaining MI and preventing premature
anaphase [73–75], and similar involvement in the prolonged MI arrest
in LT oocytes was recently reported [53, 76]. Also, as LT oocytes [53]
or mice [77] age, the MI arrest weakens, coincident with declining SAC
activity. We have shown herein that AICAR activation stimulated the
loss of chromatin MAD2 staining, in concert with promoting anaphase
onset. It is therefore likely that PRKA activator-induced loss of MAD2
kinetochore binding contributes to both its acceleration of meiosis in
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B6SJL oocytes and rescue of LT oocytes from MI arrest and activation.
Whether the action of PRKA on MAD2 dynamics is direct or indirect and
whether the mechanisms involved in the two strains are identical
remain to be determined.
Ciemerych and Kubiak [36] proposed that the lack of an
appropriate anaphase I trigger in LT oocytes may be the critical
determinant of the extended MI arrest. AICAR and, presumably, PRKA
stimulation provided such a trigger in the present study. Our data
support an alternative mechanism for PRKA action in which stimulation
of meiotic progression past MI—for example, by altering MAD2 binding
dynamics—eliminates the attenuated maturation that is essential for
activation such that oocytes driven past MI fail to activate. Indeed, on
treatment of LT oocytes with AICAR, the reduction in activation (18%;
Fig. 6A) was offset by the number of oocytes that progress to MII
(21%; Fig. 6D). Hence, it is tempting to speculate that the LT oocytes
that would have activated in the absence of AICAR are those same
oocytes stimulated to reach MII in its presence and that the nearly
complete suppression of activation is due to meiotic escape from MI.
Why the remaining MI-arrested oocytes do not activate is not clear,
but it appears that only about one-fifth of the LT oocytes are prone to
activation in our culture conditions.
Curiously, the percentage of PRKA-treated LT oocytes that
entered anaphase (33%) was higher than the number extruding a PB
(21%). This suggested that karyokinesis occurred in the absence of
cytokinesis in a small population of these oocytes. Indeed, when we
stained actin filaments with phalloidin, 4% of AICAR-treated oocytes
after 17 h of culture contained separated homologous chromosomes
with a MII spindle yet no sign of a PB or contractile ring (data not
shown). It is also possible that a small number of oocytes had
segregated homologous chromosomes that reaggregated after
anaphase onset [78, 79]. Furthermore, myosin regulatory light chain
(MRLC), an important protein involved in the regulation of contractile
ring formation, has recently been shown to be a downstream target of
PRKA [80–82]. It would be interesting to see if MRLC localization and
function is affected in LT oocytes and how it is related to the partial
rescue of meiosis I arrest by AICAR.
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When LT oocytes were stained for active PRKA after 8 h of
culture, abnormal localization was frequently observed. This was not
due to an aging effect following prolonged MI arrest because it was
observed in oocytes with newly formed meiotic spindles. Although
some B6SJL oocytes also showed abnormal spindle pole localization, it
was much less frequent. Importantly, supplementation of AICAR
significantly lowered the incidence of PRKA mislocalization in LT
oocytes, which suggests that LT oocytes may have insufficient PRKA
function. It has been reported that metaphase I-arrested LT oocytes
have more organized centrosomal material on one spindle pole than
the other [83]. This could help explain the missing or shifted spindle
pole localization of active PRKA in these oocytes since active PRKA
colocalizes with microtubule organizing centers [49].
Our results support the possibility that defective control of PRKA
activity contributes to the LT phenotype. Genes for the two PRKA
catalytic subunits, Prkaa1 and Prkaa2, are located on mouse
chromosomes 15 and 4, respectively. However, a whole genome scan
determined that regions in chromosome 1 and 9 were likely
responsible for LT oocyte defects [44]. It may be that dysregulation of
PRKA is a downstream consequence of abnormal genetic control in
these regions. Regardless, it is apparent that PRKA has a profound
influence on meiotic progression and regulation of parthenogenetic
activation in both B6SJL and LT oocytes. Up to this point, our
experiments have depended largely on pharmacological manipulation
of PRKA, and genetic ablation experiments are needed for
confirmation. Both isoforms of the catalytic subunit have been knocked
out in mice, and each is viable and able to reproduce; however, the
double knockout is an embryonic lethal [84]. It will be important to
eliminate both isoforms in the oocyte to determine if PRKA is a
requisite player or merely serves to fine-tune these physiological
processes. We are currently in the process of generating PRKA-null
oocytes to test this.

Supplementary Material
Supplemental Data:
Supplemental Figure S1. Effects of RSVA405 on oocyte maturation. A) CEO
or DO were cultured 17-18 h in medium containing 300 μM dibutyryl cyclic
adenosine monophosphate plus increasing concentrations of RSVA405 before
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assessing germinal vesicle breakdown (GVB). Meiotic resumption was induced
in both groups of oocytes (by 25% in DO and 73% in CEO). B) CEO were
cultured 17-18 h in dbcAMP alone or with additional supplements of 2 μM
RSVA405 ± 2.5 μM compound C (PRKA inhibitor). The inhibitor completely
blocked RSVA40s-induced maturation. C) CEO were cultured 15-16 h in
control medium containing increasing concentrations of RSVA405 and
assessed for polar body formation. The drug stimulated polar body formation
in dose-dependent fashion. Data are presented as mean percent GVB or polar
body (PB) ± SEM. For B and C, groups with no common letter are significantly
different.
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